Key points include: Starting Dose : Typically begins at a low dose to minimize side effects
Sezen S, Karadayi M, Yesilyurt F, Burul F, Gulsahin Y, Ozkaraca M, Okkay U, Gulluce M (2025) Acyclovir provides protection against 6-OHDA-induced neurotoxicity in SH-SY5Y cells through the kynurenine pathway
Based on these results, the FDA approved Wegovy for cardiovascular risk reduction in March 2024 making it the first weight-loss medication approved to prevent cardiovascular events
If you are pregnant or planning pregnancy, inform your doctor before receiving this medicine
If you are traveling through airport security, carry a prescription label and a letter from your healthcare provider to avoid any complications